The Cigna Group (CI) | Rumor.io

The Cigna Group

Attention (50-day avg)0%

Attention rank (50-day avg)#887

Bullish sentiment (50-day avg)99%

Price to earnings ratio11.2

Market capitalization71.8B

Earnings per share24.2

Dividend yield (TTM)2.29%

Revenue (annual)273.9B

Net income (annual)6.3B

Social

What share of all stock conversation is about CI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Aug 31

Cigna (CI) is considered undervalued by some investors, with a recent decline in price making it an interesting buy.
The company's dividend yield is seen as relatively low compared to its peers, and its growth prospects are viewed as weak.
Some investors are optimistic about Cigna's prospects, expecting it to catch up with UnitedHealth (UNH) in the near future.

Generated by AI

Sentiment

Of the messages about CI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	100% +0.92	64.27% -19.97
Bearish	—	0%	0% -0.92	35.73% +19.97

Bullish· Feb 5

Cigna Group ($CI) Q4 earnings beat estimates, driven by strong performance from Evernorth Health Services and new business growth.
The company's adjusted EPS reached $8.08, with revenue of $72.47B and net income of $1.23B, supported by improved cost efficiency.
Cigna's specialty growth is a key driver of its success, with the company seeing an increase in specialty volumes that offset fewer medical customers and elevated costs.

Bearish· Oct 30

The Cigna Group's ($CI) PBM segment is exposed to regulatory risk, which has weighed on its valuation despite growing EPS at a 13% CAGR over 10 years.
$CI's business model shift to a fee-based model is a source of uncertainty for investors, which the stock market tends to dislike.
$CI's acquisition of Express Scripts for $50 billion may be considered a misstep, as the company is now facing regulatory pressure and potentially obsolete technology, making it "almost worthless" now.

Generated by AI

Topics

Of the messages about CI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	0%	4.79%
Earnings	—	—	31.36%	10.31%
Macro	—	—	31.6%	21.61%
Announcements	—	—	5.93%	35.83%
Analysts	—	—	31.11%	25.84%
Controversies	—	—	0%	1.62%

Earnings· Oct 30

Cigna's Q3 2025 earnings report shows revenue of $69.7B, a 10% YoY increase, and adjusted EPS of $7.83, beating estimates by $0.19.
The company's Evernorth segment reported a 15% YoY revenue increase, with pre-tax AOI of $1.90B.
Cigna reaffirmed its FY25 adjusted EPS outlook of at least $29.60, matching the consensus estimate.

Analysts· Jun 22

Morgan Stanley upgraded Cigna's rating to "Overweight" and raised its price target from $283 to $296.
AM Best revised its issuer credit rating outlook for Cigna and most of its subsidiaries to positive, affirming their credit ratings.
Morgan Stanley analyst Ricky Goldwasser upgraded Cigna to "Overweight" and raised the price target from $283 to $296.

Announcements· Mar 3

Cigna has announced that David Cordani will retire as CEO on July 1, 2026, and be replaced by Brian Evanko, who will become the new CEO.
The company has reaffirmed its outlook for 2026, with the CFO previously affirming the company's expectations for the year.
Brian Evanko, the new CEO, is a 28-year veteran of the company and has been serving as President and COO, and will take on the role of CEO effective July 1, 2026.

Controversies· Sep 17

The US Department of Justice has cleared Cigna's acquisition of Express Scripts, a deal worth $68 billion.
The clearance is a positive sign for CVS Health and Aetna, which may benefit from the merger.
The deal's approval is seen as a key milestone in the consolidation of the US healthcare industry.

Macro· Feb 4

The author suggests that UnitedHealth Group (UNH) investors are making emotional decisions rather than understanding the company's underlying policies, which have led to the demise of prior generations of insurers.
The author believes that the Centers for Medicare and Medicaid Services (CMS) slowly compresses margins through regulated pricing and rising medical costs, leading to the death of traditional spread pricing business models.
The author notes that companies like Aetna and Cigna have adapted to this environment by pivoting into Pharmacy Benefit Managers (PBMs) or merging with other companies to survive.

Generated by AI

Community

Of the messages about CI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	15.38%	3.88%	53.93%
Newcomers	—	84.62%	96.12%	46.07%

Regulars· Feb 5

CI's valuation is the lowest among health insurers, despite having a predictable business with 80% being fee-based and 20% insurance-based.
The company's Q4 results were strong, with adjusted EPS of $8.08 and revenue of $72.47B, driven by Evernorth performance and improved cost efficiency.
CI's 2026 EPS guidance of $30.25 is in-line, but the company faces cost pressure and a softer top-line, which may keep sentiment in check.

Newcomers· Aug 31

The newcomer is considering Cigna (CI) after its recent decline, finding its valuation interesting.
Cigna is seen as a dividend stock with a relatively low dividend yield, compared to other investment options.
The newcomer suggests that Cigna's price is not attractive, citing slower revenue growth rate, lack of a catalyst, and low margins in its insurance management segment.

Generated by AI

News

Cigna Stock in Focus as Investor Day Spotlights Specialty Drugs

20h agoBarron's

GLP-1 Users Are Furious After Employers Drop Insurance Benefits

7d agoBloomberg.com

Can Cigna's AI Push Help Rein In Rising Healthcare Costs?

CI is expanding AI across care coordination and specialty pharmacy as it seeks to manage elevated healthcare costs and improve access.

11d agoYahoo Finance

Cigna Group stock underperforms Thursday when compared to competitors

12d agoMarketWatch

Is Volunteering Good for Your Health? New Research From The Cigna Group Finds a Strong Connection

New research from The Cigna Group (NYSE: CI) finds that volunteering is associated with better health, stronger workplace engagement, and greater connection to community. According to the company's fifth annual Vitality in America report, people who volunteer are nearly twice as likely to report high vitality, a measure of how healthy, connected, and capable a person feels. The research also found that employees who participate in employer-supported volunteer activities are significantly more li

13d agoYahoo Finance

Is Cigna Group (CI) Still Undervalued Or Are The Risks Keeping It Fairly Priced?

Cigna Group (CI) continues to draw attention after its recent close at US$288.90, with investors weighing modest return figures across the past week, month, and past 3 months against the insurer's broader long term track record. Recent trading has been more mixed for Cigna Group, with the share price slipping 0.4% on the day but still posting a 4.7% 7 day gain and a 3.5% year to date share price return. The 1 year total shareholder return of 0.4% and 5 year total shareholder return of 56.7%...

14d agoYahoo! Finance Canada

Also Discussed

Investors talking about CI also mention

#	Name	Attention
1	Humana Inc.HUM	0%+0
2	Elevance Health, Inc.ELV	0%new
3	Centene CorpCNC	0%0
4	Molina Healthcare Inc.MOH	0%new
5	CVS Health CorporationCVS	0%0
6	UnitedHealth Group IncorporatedUNH	0%-0.02
7	ANTM - Elevance Health Inc.	——
8	Universal Health Services Inc. Class B Common StockUHS	0%0
9	HCA Healthcare Inc.HCA	0%0
10	Alignment Healthcare, Inc.ALHC	0%0

The Cigna Group

Healthcare
Healthcare Plans

The Cigna Group is a global health company focused on providing health services, insurance products, and related support solutions. The company operates through two core business segments: Cigna Healthcare and Evernorth Health Services, which together serve employers, individuals, health plans, government programs, and other organizations. Its offerings include medical, dental, behavioral, disability, and life insurance, along with pharmacy benefit management, specialty pharmacy, care coordination, and other clinical and administrative services. The Cigna Group plays an important role in the healthcare market by connecting insurance coverage with pharmacy and care management capabilities, helping clients and members access coordinated health benefits and services across the United States and selected international markets. Headquartered in Bloomfield, Connecticut, The Cigna Group remains a major diversified healthcare services provider.

Website

Location

900 Cottage Grove Road

Bloomfield, CT, 06002

United States

Social

What share of all stock conversation is about CI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Aug 31

Cigna (CI) is considered undervalued by some investors, with a recent decline in price making it an interesting buy.
The company's dividend yield is seen as relatively low compared to its peers, and its growth prospects are viewed as weak.
Some investors are optimistic about Cigna's prospects, expecting it to catch up with UnitedHealth (UNH) in the near future.

Generated by AI

Sentiment

Of the messages about CI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	100% +0.92	64.27% -19.97
Bearish	—	0%	0% -0.92	35.73% +19.97

Bullish· Feb 5

Cigna Group ($CI) Q4 earnings beat estimates, driven by strong performance from Evernorth Health Services and new business growth.
The company's adjusted EPS reached $8.08, with revenue of $72.47B and net income of $1.23B, supported by improved cost efficiency.
Cigna's specialty growth is a key driver of its success, with the company seeing an increase in specialty volumes that offset fewer medical customers and elevated costs.

Bearish· Oct 30

The Cigna Group's ($CI) PBM segment is exposed to regulatory risk, which has weighed on its valuation despite growing EPS at a 13% CAGR over 10 years.
$CI's business model shift to a fee-based model is a source of uncertainty for investors, which the stock market tends to dislike.
$CI's acquisition of Express Scripts for $50 billion may be considered a misstep, as the company is now facing regulatory pressure and potentially obsolete technology, making it "almost worthless" now.

Generated by AI

Topics

Of the messages about CI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	0%	4.79%
Earnings	—	—	31.36%	10.31%
Macro	—	—	31.6%	21.61%
Announcements	—	—	5.93%	35.83%
Analysts	—	—	31.11%	25.84%
Controversies	—	—	0%	1.62%

Earnings· Oct 30

Cigna's Q3 2025 earnings report shows revenue of $69.7B, a 10% YoY increase, and adjusted EPS of $7.83, beating estimates by $0.19.
The company's Evernorth segment reported a 15% YoY revenue increase, with pre-tax AOI of $1.90B.
Cigna reaffirmed its FY25 adjusted EPS outlook of at least $29.60, matching the consensus estimate.

Analysts· Jun 22

Morgan Stanley upgraded Cigna's rating to "Overweight" and raised its price target from $283 to $296.
AM Best revised its issuer credit rating outlook for Cigna and most of its subsidiaries to positive, affirming their credit ratings.
Morgan Stanley analyst Ricky Goldwasser upgraded Cigna to "Overweight" and raised the price target from $283 to $296.

Announcements· Mar 3

Cigna has announced that David Cordani will retire as CEO on July 1, 2026, and be replaced by Brian Evanko, who will become the new CEO.
The company has reaffirmed its outlook for 2026, with the CFO previously affirming the company's expectations for the year.
Brian Evanko, the new CEO, is a 28-year veteran of the company and has been serving as President and COO, and will take on the role of CEO effective July 1, 2026.

Controversies· Sep 17

The US Department of Justice has cleared Cigna's acquisition of Express Scripts, a deal worth $68 billion.
The clearance is a positive sign for CVS Health and Aetna, which may benefit from the merger.
The deal's approval is seen as a key milestone in the consolidation of the US healthcare industry.

Macro· Feb 4

The author suggests that UnitedHealth Group (UNH) investors are making emotional decisions rather than understanding the company's underlying policies, which have led to the demise of prior generations of insurers.
The author believes that the Centers for Medicare and Medicaid Services (CMS) slowly compresses margins through regulated pricing and rising medical costs, leading to the death of traditional spread pricing business models.
The author notes that companies like Aetna and Cigna have adapted to this environment by pivoting into Pharmacy Benefit Managers (PBMs) or merging with other companies to survive.

Generated by AI

Community

Of the messages about CI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	15.38%	3.88%	53.93%
Newcomers	—	84.62%	96.12%	46.07%

Regulars· Feb 5

CI's valuation is the lowest among health insurers, despite having a predictable business with 80% being fee-based and 20% insurance-based.
The company's Q4 results were strong, with adjusted EPS of $8.08 and revenue of $72.47B, driven by Evernorth performance and improved cost efficiency.
CI's 2026 EPS guidance of $30.25 is in-line, but the company faces cost pressure and a softer top-line, which may keep sentiment in check.

Newcomers· Aug 31

The newcomer is considering Cigna (CI) after its recent decline, finding its valuation interesting.
Cigna is seen as a dividend stock with a relatively low dividend yield, compared to other investment options.
The newcomer suggests that Cigna's price is not attractive, citing slower revenue growth rate, lack of a catalyst, and low margins in its insurance management segment.

Generated by AI

The Cigna Group

Social

Aug 31

Bullish· Feb 5

Bearish· Oct 30

Earnings· Oct 30

Analysts· Jun 22

Announcements· Mar 3

Controversies· Sep 17

Macro· Feb 4

Regulars· Feb 5

Newcomers· Aug 31

Cigna Stock in Focus as Investor Day Spotlights Specialty Drugs

GLP-1 Users Are Furious After Employers Drop Insurance Benefits

Can Cigna's AI Push Help Rein In Rising Healthcare Costs?

Cigna Group stock underperforms Thursday when compared to competitors

Is Volunteering Good for Your Health? New Research From The Cigna Group Finds a Strong Connection

Is Cigna Group (CI) Still Undervalued Or Are The Risks Keeping It Fairly Priced?

Also Discussed

The Cigna Group

Company Information

Location

Cigna Stock in Focus as Investor Day Spotlights Specialty Drugs

GLP-1 Users Are Furious After Employers Drop Insurance Benefits

Can Cigna's AI Push Help Rein In Rising Healthcare Costs?

Cigna Group stock underperforms Thursday when compared to competitors

Is Volunteering Good for Your Health? New Research From The Cigna Group Finds a Strong Connection

Is Cigna Group (CI) Still Undervalued Or Are The Risks Keeping It Fairly Priced?

Also Discussed

Social

Aug 31

Bullish· Feb 5

Bearish· Oct 30

Earnings· Oct 30

Analysts· Jun 22

Announcements· Mar 3

Controversies· Sep 17

Macro· Feb 4

Regulars· Feb 5

Newcomers· Aug 31